Yuda, J., Odawara, J., Minami, M., Muta, T., Kohno, K., Tanimoto, K., . . . Miyamoto, T. (2020). Tyrosine kinase inhibitors induce alternative spliced BCR‐ABL (Ins35bp) variant via inhibition of RNA polymerase II on genomic BCR‐ABL. Cancer Sci.
Citação norma ChicagoYuda, Junichiro, et al. "Tyrosine Kinase Inhibitors Induce Alternative Spliced BCR‐ABL (Ins35bp) Variant Via Inhibition of RNA Polymerase II On Genomic BCR‐ABL." Cancer Sci 2020.
Citação norma MLAYuda, Junichiro, et al. "Tyrosine Kinase Inhibitors Induce Alternative Spliced BCR‐ABL (Ins35bp) Variant Via Inhibition of RNA Polymerase II On Genomic BCR‐ABL." Cancer Sci 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.